secwatch.observer — SEC 8-K summary
======================================

Issuer:     PALISADE BIO, INC. (PALI)
CIK:        0001357459
Form:       8-K
Filed at:   2024-09-27T23:59:59+00:00
Accession:  0001493152-24-038547
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Palisade Bio revises CEO/CFO J.D. Finley's employment agreement; salary unchanged
--------------------------------------------------------------------------------

- Base salary stays at $542,000 per year; target bonus remains up to 50% of base.
- Non-CIC severance: 12 months base salary continuation plus COBRA premiums.
- CIC severance: lump sum of 18 months base plus 100% target bonus, 18 months COBRA, full acceleration of time-based equity.
- Agreement is at-will; executive must sign release for severance benefits.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1357459/000149315224038547/0001493152-24-038547-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1357459/000149315224038547/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-038547

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer